What is the price target for CRH stock?
30 analysts have analysed CRH and the average price target is 143.57 USD. This implies a price increase of 24.35% is expected in the next year compared to the current price of 115.45.
NYSE:CRH • IE0001827041
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CRH PLC (CRH).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-15 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2026-03-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-03-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-02-20 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-29 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-13 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2026-01-08 | UBS | Maintains | Buy -> Buy |
| 2026-01-08 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-16 | Longbow Research | Initiate | Buy |
| 2025-12-10 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-12 | DA Davidson | Maintains | Neutral -> Neutral |
| 2025-11-11 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-20 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-14 | UBS | Initiate | Buy |
| 2025-10-08 | Wells Fargo | Initiate | Overweight |
| 2025-10-02 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-01 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-26 | B of A Securities | Reiterate | Buy |
| 2025-09-11 | Bernstein | Maintains | Outperform -> Outperform |
| 2025-08-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-10 | DA Davidson | Downgrade | Buy -> Neutral |
| 2025-04-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-09 | Loop Capital | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 34.949B 6.80% | 35.572B 1.78% | 37.447B 5.27% | 40.095B 7.07% | 42.192B 5.23% | 44.976B 6.60% | 47.714B 6.09% | 51.109B 7.12% | |
| EBITDA YoY % growth | 6.12B 11.78% | 6.72B 9.80% | 7.479B 11.29% | 8.414B 12.50% | 9.025B 7.26% | 9.79B 8.48% | 10.049B 2.65% | 11.411B 13.55% | |
| EBIT YoY % growth | 4.487B 15.11% | 4.922B 9.69% | 5.323B 8.15% | 6.102B 14.63% | 6.638B 8.78% | 7.227B 8.87% | 7.856B 8.70% | 8.551B 8.85% | |
| Operating Margin | 12.84% | 13.84% | 14.21% | 15.22% | 15.73% | 16.07% | 16.46% | 16.73% | |
| EPS YoY % growth | N/A 16.89% | 4.76 5.09% | 5.57 17.02% | 6.06 8.87% | 6.81 12.27% | 7.66 12.58% | 8.13 6.11% | 8.67 6.59% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.17 10.53% | 2.49 12.82% | 1.58 4.71% | -0.27 -36.35% | 2.38 10.03% | 2.75 10.32% | 1.74 10.30% |
| Revenue Q2Q % growth | 10.841B 6.22% | 11.811B 6.70% | 9.901B 5.15% | 7.34B -0.41% | 11.306B 4.29% | 12.395B 4.94% | 10.158B 2.60% |
| EBITDA Q2Q % growth | 2.68B -8.25% | 2.957B -17.70% | 2.051B -42.50% | 533.28M -2.54% | 2.83B 5.60% | 3.183B 7.64% | 2.244B 9.41% |
| EBIT Q2Q % growth | 2.119B 10.59% | 2.398B 20.68% | 1.528B 8.29% | -84.335M -627.75% | 2.269B 7.08% | 2.591B 8.05% | 1.588B 3.93% |
All data in USD
30 analysts have analysed CRH and the average price target is 143.57 USD. This implies a price increase of 24.35% is expected in the next year compared to the current price of 115.45.
The consensus EPS estimate for the next earnings of CRH PLC (CRH) is 2.17 USD and the consensus revenue estimate is 10.84B USD.
The expected long term growth rate for CRH PLC (CRH) is 5.85%.